Table IV.
Variables | OR | 95% CI | P-value |
---|---|---|---|
Sex | 0.727 | ||
Male | 1 | Referent | |
Female | 0.85 | 0.351-2.075 | |
Age (years) | 0.98 | 0.944-1.011 | 0.177 |
BMI | 0.91 | 0.793-1.040 | 0.164 |
Phase of HBV infection | 0.019 | ||
Active HBV infection | 1 | Referent | |
Inactive HBV carrier | 0.35 | 0.143-0.842 | |
Cirrhosis | 0.50 | 0.097-2.546 | 0.402 |
Diabetes | 1.26 | 0.330-4.842 | 0.732 |
Hypertension | 1.03 | 0.315-3.377 | 0.959 |
Hyperuricemia | 1.09 | 0.188-6.277 | 0.925 |
PLT (x104/µl) | 1.04 | 0.983-1.108 | 0.167 |
AST (U/l) | 0.96 | 0.906-1.014 | 0.139 |
ALT (U/l) | 0.99 | 0.967-1.019 | 0.572 |
T–BIL (mg/dl) | 0.86 | 0.197-3.800 | 0.847 |
FIB-4 index | 0.72 | 0.445-1.164 | 0.180 |
APRI | 0.09 | 0.006-1.502 | 0.094 |
OR, odds ratio; CI, confidence interval; HBV, hepatitis B virus; BMI, body mass index; PLT, platelet count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; T-BIL, total bilirubin; FIB-4, fibrosis-4; APRI, AST to platelet ratio index.